FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Fakultät
Tampere University Hospital
Tampere, FinlandiaPublikationen in Zusammenarbeit mit Forschern von Tampere University Hospital (3)
2023
-
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis
Radiotherapy and Oncology, Vol. 186
2013
-
Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: Results from the randomised, placebo-controlled avodart after radical therapy for Prostate Cancer Study (ARTS)
European Urology, Vol. 63, Núm. 5, pp. 779-787
-
Reply from authors re: Behfar Ehdaie, Karim A. Touijer. 5-Alpha reductase inhibitors in prostate cancer: From clinical trials to clinical practice. Eur Urol 2013;63:788-9: 5-Alpha reductase inhibitors in prostate cancer
European Urology